Specific Gene Co-variation Acts Better Than Number of Concomitant Altered Genes in Predicting EGFR-TKI Efficacy in Non-small-cell Lung Cancer.
第一作者:
Yan-Juan,Zhu
第一单位:
Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
作者:
医学主题词
癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);癌, 鳞状细胞(Carcinoma, Squamous Cell);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);预后(Prognosis);前瞻性研究(Prospective Studies);蛋白激酶抑制剂(Protein Kinase Inhibitors);存活率(Survival Rate)
DOI
10.1016/j.cllc.2020.09.003
PMID
33067127
发布时间
2021-12-14
- 浏览2
Clinical lung cancer
e98-e111页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



